Recent developments in the treatment of osteoarthritis

Bibliography

• ALTMAN R, ASCH E, BLOCK D, et al.: Development of criteria for the classification and reporting of OA. Classification of OA of the knee. Arthritis Rheum. (1986) 29:1039–1049.
   PubMed Web of Science ®Google Scholar
• POCOCK N, EISMAN J, HOPPER J, et al.: Genetic determinants of bone mass in adults. J. Clin. Investig. (1987) 80:706–710.
   PubMed Web of Science ®Google Scholar
• COOPER C, MCALINDON T, SNOW S, et al.: Mechanical and constitutional factors for symptomatic knee osteoarthritis; differences between medial tibio-femoral and patello-femoral disease. J. Rheum. (1994) 21:307–313.
   PubMed Web of Science ®Google Scholar
• KELLGREN JH, LAWRENCE JS, BIER F: Genetic factors in generalised osteoarthritis. Annals Rheum. Dis. (1963) 22:237–255.
   PubMed Web of Science ®Google Scholar
• FELSON DT, ANDERSON JJ, NAIMARK A, et al.: Obesity and knee osteoarthritis. The Framingham Study. Annals mt. Med. (1988) 109:18–24.
   PubMed Web of Science ®Google Scholar
• Osteoarthritic Disorders. Keuttner K, Goldberg Em (Eds.), American Academy of Orthopedic Surgeons, Rosemont, USA (1995):xxi-xxy.
   Google Scholar
• KELLGRAN JH, LAWRENCE JS: Radiologic assessment of OA. Ann. Rheum. Dis. (1957) 16:494–501.
   PubMed Web of Science ®Google Scholar
• SPECTOR TD, COOPER C: Radiologic assessment of OA in population studies. Osteoarth. Cartilage (1993) 1:203–206.
   PubMedGoogle Scholar
• VELDHUIJZEN JP, BOURRET LA, RODAN GA: In vitro studies of the effect of intermittent compressive forces on cartilage cell proliferation. J. Cell Physiol. (1979) 98:299–306.
   PubMed Web of Science ®Google Scholar
• JONES IL, KLAMFELDT A, SANDSTROM T: The effect of continuous mechanical pressureupon the turnover of articular cartilage proteoglycans in vitro. Clin. Ortho. (1982) 65:283–289.
   Google Scholar
• PALMOSKI MJ, BRANDT KD: Effects of static and cyclic compressive loading on articular cartilage plugs in vitro. Arth. Rheum. (1984) 27:675–681.
   PubMed Web of Science ®Google Scholar
• DEWITT MT, HANDLEY CJ, OAKES BW, LOWTHER DA: In vitro response of chondrocytes to mechanical loading. The effect of short-term mechanical tension. Connect. Tiss. Res. (1984) 12:97–109.
   PubMed Web of Science ®Google Scholar
• VAN KAMPEN GPJ, VLEDJUIJZEN JP, KUIJER R, et al.: Cartilage response to mechanical force in high density chondrocyte cultures. Arth. Rheum. (1985) 28:419–424.
   PubMed Web of Science ®Google Scholar
• BUTTLE DJ, BRAMVVELL H, HOLLANDER AP: Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy J. Clin. Pathol. Mol. Path. (1995) 48:M167–177.
   Web of Science ®Google Scholar
• CHIKANZA IC, GROSSMAN AS: Neuroendocrine immune responses to inflammation:the concept of the neuroendocrine immune loop. Bailliere's Clin. Rheum. (1996) 10:199–225.
   PubMed Web of Science ®Google Scholar
• CUTIGNOLA L, BULLOUGH PG: Photographic reproduction of anatomical specimens using illumination. Am. J. Surg. Pathol. (1991) 15:1096–1099.
   PubMed Web of Science ®Google Scholar
• ITO S, BULLOUGH PG: Synovial and osseous inflammation in degenerative joint disease and rheumatoid arthritis of the hip. In: Proceedings of the 25th Annual Meeting of the ORS. (1979).
   Google Scholar
• SPECTOR TD, HART DJ, NANDRA D, et al.: Low-level increases in serum C-reactiveprotein are present in early osteoarthritis of the knee and predict progressive disease. Arth. Rheum. (1997) 40:723–727.
   PubMed Web of Science ®Google Scholar
• CHRISTOPHERSON KS, BREDT DS: Perspective series: nitric oxide and nitric synthases.Nitric oxide in excitable tissues: pathophysiologic roles in disease. J. Clin. Invest. (1997) 100:242–249.
   Web of Science ®Google Scholar
• OATES JC, RUIZ P, ALEXANDER A, PIPPEN AM, GILKERSON GS: Effect of latemodulation of NO production on murine lupus. Clin. Immunol. Immunopathol. (1997) 83:86–92.
   PubMedGoogle Scholar
• STEFANOVIC-RACIC M, STADLER J, EVANS CH: Nitric oxide and arthritis. Arth. Rheum. (1993) 36:1036–1044.
   PubMed Web of Science ®Google Scholar
• PELLETIER J-P, JOVANOVIC D, FERNANDES JC, et al.: Selective inhibition of nitric oxide synthase reduces in vivo the progression of experimental osteoarthritic lesions and production of metalloproteases and interleukin-1. Arth. Rheum. (1997) 40 (Suppl. 9) :S173.
   Google Scholar
• HASHIMOTO S, TAKHASHI K, AMIEL D, COUTTS R, LOTZ M: Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arth. Rheum. (1998) 41:1266–1274.
   PubMed Web of Science ®Google Scholar
• AMIN AR, DI CESARE PE, VYAS et al.: The expression and regulation of nitric oxidesynthase in human osteoarthritis-affected chondrocytes: evidence for upregulated neuronal nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for upregulated neuronal nitric oxide synthase. J. Exp. Med. (1995) 182:2097–2102.
   PubMed Web of Science ®Google Scholar
• AMIN AR, PATEL P, VYAS P, DI CESARE PE, ATTUR M, ABRAMSON SB: Nitric oxideproduced by cartilate-specific nitric oxide synthase is a common mediator of cartilage degradation in both rheumatoid arthritis and osteoarthritis [abstract]. J. Invest. Res. (1996) 44:236A.
   Google Scholar
• GLANT TT, CS-SZABO G, NAGASE H, JACOBS JJ, MIKECZ K: Progressive polyarthritisinduced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage. Arth. Rheum. (1998) 41:1007–1018.
   PubMed Web of Science ®Google Scholar
• BRANDT KD: Should non-steroidal anti-inflammatory drugs be used to treat osteoarthritis Rheum. Dis. Clinic. North Am. (1993) 19:29–44.
   PubMed Web of Science ®Google Scholar
• LORIG KR, MAZONSON PD, HOLMAN HR: Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs. Arth. Rheum. (1993) 36:439–446.
   PubMed Web of Science ®Google Scholar
• HAMPSON SE, GLASGOW RE, ZEISS AM, BIRSKOVICH SF, FOSTER L, LINES A: Self-management of osteoarthritis. Arth. Care Res. (1993) 6:17–22.
   PubMedGoogle Scholar
• RASHAD S, REVELL P, HEMMINGWAY A, et al.: Effect of NSAIDs on the course of osteoarthritis. Lancet (1989) 2:519–522.
   PubMed Web of Science ®Google Scholar
• FRIEDMAN DM, MORRE ME: The efficacy of intra-articular steroids in osteoarthritis: adouble blind study. J. Rheumatol. (1980) 7:1850–1856.
   Web of Science ®Google Scholar
• DIEPPE PA, SATHAPATAYAVONGS B, JONES HE, et al.: Intra-articular steroids in osteoarthritis. Rheumatol. Rehabil. (1980) 19:212–217.
   PubMedGoogle Scholar
• GAFFNEY K, LEDINGHAM J, PERRY JD: Intra-articular triamcinolone hexacetonide in knee osteoarthritis: factors influencing the clinical response. Ann. Rheum. Dis. (1995) 54:379–381.
   PubMed Web of Science ®Google Scholar
• DIEPPE P: Should intra-articular steroids be used in osteoarthritis Br. J. Rheum. (1991)20:199.
   Google Scholar
• ADAMS ME: An analysis of clinical studies of the use of cross-linked hyaluronan. nyalan,in the treatment of osteoarthritis. J. Rheumatol. (1993) 20 (Suppl. 39):16–18.
   Google Scholar
• LOHMANDER LS, DALEN N, ENGLUNO G, et al.: Intra-articular hyaluronan injections inthe treatment of osteoarthritis of the knee; a randomised double blind, placebo controlled multicentre trial. Ann. Rheum. Dis. (1996) 55:424–431.
   PubMed Web of Science ®Google Scholar
• Diclofenac gel - topical NSAIDs and science. Drug Ther. Bull. (1991) 29:95–96.
   PubMedGoogle Scholar
• ALTMAN RD, AVEN A., HOLMBERG CE, PFEIFER LM, SACK M, YOUNG GT: Capsaicincream 0.025% as monotherapy for osteoarthritis: a double blind study. Semin. Arth. Rheum. (1994) 23\(Suppl. 3):25–33.
   Google Scholar
• DOHERTY M, DIEPPE PA: Effect of intra-articular yttrium-90(90Y)on chronicpyrophosphate arthropathy of the knee. Lancet (1981) 2 (i):1243–1245.
   PubMedGoogle Scholar
• BRADY S, BROOKS P, CONAGHAN P, KENYON LM: Pharmacotherapy and osteoarthritis. Bailliere's Clin. Rheumatol. (1997) 11:749–768.
   PubMed Web of Science ®Google Scholar
• HAYLLAR J, BJARNASON I: NSAIDs, Cox-2 inhibitors, and the gut. Lancet (1995) 346:521–522.
   PubMed Web of Science ®Google Scholar
• AMADIO P, CUMMINGS DM: Evaluation of acetominophen in the mangement of OA of the knee. Curr. Ther. Res. (1983) 34:59–66.
   Web of Science ®Google Scholar
• KJAERSGAARD-ANDERSEN P, NAFEI A, et al.: Codeine plus paracetamol versus paracetamol in the longterm treatment of chronic pain due to OA of the hip. A randomised, double blind multicentre study. Pain (1990) 43:309–318.
   PubMed Web of Science ®Google Scholar
• LYOYD RS, COSTELLO F, EVES MJ, et al.: The efficacy and tolerability of controlled release dihydrocodeine tablets and combination detropoxyphene/paracetamol tablets in patients with severe OA of the hips. Curr. Med. Res. Opin. (1992) 13:37–48.
   PubMed Web of Science ®Google Scholar
• HENRY D, LIM LL, RODRIGUEZ LA, et al. Variability in the risk of gastrointestinal complications with individual NSAIDs: results of a collaborative meta-analysis. Br. Med. J. (1996) 312:1563–1566.
   PubMed Web of Science ®Google Scholar
• EVANS JM, MACDONALD TM: tolerability of topical NSAIDs in the elderly. Drugs Aging(1996) 9:101–108.
   PubMed Web of Science ®Google Scholar
• BRANDT KD: Toward pharmacological modification ofjoint damage in OA. Ann. Int. Med. (1995) 122:874–875.
   PubMed Web of Science ®Google Scholar
• RYAN ER, GREENWALD RA, GOLUB LM: Potential of tetracyclines to modify cartillage breakdown in OA. Curr. Opin. Rheum. (1996) 8:238–247.
   PubMedGoogle Scholar
• FERNANDEZ JC, CARON JP, MARTEL-PELLETIER J, et al.: Effects of Tenidap on theprogression of osteoarthritic lesions in a canine experimental model. Arth. Rheum. (1997) 40:284–294.
   PubMed Web of Science ®Google Scholar
• MARCH LM, BACHMEIER CJM: Economics of osteoarthritis: a global perspective.Bailliere's Clin. Rheumatol. (1997) 11:817–834.
   PubMed Web of Science ®Google Scholar
• Bowman WC, Fitzgerald JD, Taylor JB (Eds.), Ashley Publications Ltd, London, UK (1997) :269–286.
   Google Scholar
• PELLETIER J-P, JOVANOVIC D, FERNANDES JC, et al.: Reduced progression ofexperimental OA in vivo by selective inhibition of inducible NO synthase. Arth. Rheum. (1998) 41:1275–1286.
   PubMed Web of Science ®Google Scholar
• DEAN DD, MARTEL-PELLETIER J, PELLETIER JP, HOWELL DS, WOESSNER JF:Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritis cartilage. J. Clin. Invest. (1989) 84:678–685.
   PubMed Web of Science ®Google Scholar
• CHIKANZA IC, FERNANDES L: The current and future prospects for biological targetedtherapies for rheumatoid arthritis. Exp. Opin. Invest. Drugs (1996) 5(7)819–828.
   Google Scholar
• ROESSLER FJ, ALLEN ED, WILSON JM, HARTMAN JW, DAVIDSON BL:Adenoviral-mediated gene transfer to rabbit synovium in vivo. J. Clin. Invest. (1993) 92:1085–1092.
   PubMed Web of Science ®Google Scholar
• HARTMAN JW, DAVIDSON BL, ROESSLER FJ: Genetic modification of synoviocytes in vivo using recombinant adenoviral vectors. Arth. Rheum. (1993) 36:S64.
   Google Scholar
• BANDARA G, MUELLER GM, GALEA-LAURI J, et al.: Intra-articular expression of biologically active interleukin-1 receptor antagonist protein by ex vivo gene transfer. Proc. Natl. Acad. Sci. USA (1993) 90:10764–10768.
   PubMed Web of Science ®Google Scholar
• REJHOLEC V: Longterm studies of anti-osteoarthritic drugs: An assessment. Semin. Arth.Rheum. (1987) 17\(Suppl. 1)35–53.
   PubMedGoogle Scholar